New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 5, 2012
08:04 EDTMDT, ABMD, THORThe FDA Circulatory Systems Devices Panel holds a meeting
The Panel discusses and makes recommendations regarding the 515(i) order issued by the FDA on April 9, 2009 , for the external counter-pulsating (ECP) devices and the Intra-aortic balloon and control systems, one of the remaining pre-Amendment Class III devices, in a meeting being held in Gaithersburg, Maryland on December 5 at 8 am. Webcast Link
News For MDT;THOR;ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 22, 2015
07:00 EDTTHORSt. Jude Medical to acquire Thoratec for $63.50 per share, deal valued at $3.4B
Subscribe for More Information
July 21, 2015
16:28 EDTTHOROn The Fly: Top stock stories for Tuesday
Subscribe for More Information
15:08 EDTTHORThoratec reaches all-time high after report of St. Jude takeover
Subscribe for More Information
14:52 EDTTHORThoratec could possibly get $65-$70 per share in takeover, says Northland
Subscribe for More Information
13:56 EDTTHORSt. Jude Medical bid for Thoratec makes strategic sense, says JPMorgan
Subscribe for More Information
12:40 EDTTHORSt. Jude in talks to acquire Thoratec, Bloomberg reports
St. Jude Medical (STJ) is in talks to acquire Thoratec (THOR), Bloomberg reports, citing people familiar with the situation. Talks are ongoing and could still fall apart as no deal has been reached, Bloomberg adds. Thoratec shares spiked early in today's session, but a catalyst for the move was unclear before the Bloomberg report. Shares of the medical device maker focused on advanced heart failure patients are up $9.52 to $58.33 in midday trading. Its close competitor HeartWare (HTWR) is now up $5.53 to $84.70. Shares of St. Jude are up 4 to $76.61. Reference Link
12:33 EDTTHORThoratec jumps after Bloomberg report of St. Jude buyout talks
Subscribe for More Information
12:29 EDTTHORSt. Jude Medical in talks to acquire Thoratec, Bloomberg reports
Subscribe for More Information
12:21 EDTTHOROn The Fly: Top stock stories at midday
Subscribe for More Information
10:20 EDTTHORCatalyst behind Thoratec spike higher unclear
The catalyst behind the spike higher in shares of Thoratec (THOR) is unclear to traders and investors. The medical device maker focused on advanced heart failure patients rose as high $62.05 in early trading and its shares remain up 11%, or $5.48, to $54.29. Some vague takeover chatter surfaced, with St. Jude Medical (STJ) as the speculated buyer, but buyout rumors are often the "go-to" reason when stocks spike. Often the moves on rumors are less substantial than Thoratec's spike today. The company's close competitor HeartWare (HTWR) is not seeing any unusual trading thus far today, falling 36c to $78.81 in early trading.
10:14 EDTTHORHigh option volume stocks:
Subscribe for More Information
10:12 EDTTHORThoratec calls active on sharp rally
Thoratec August 55 and 65 calls are active on 260 contracts (50 puts). August call option implied volatility is at 55, September is at 50; compared to its 52-week range of 24 to 51. Active calls suggests traders taking positions for price movement.
09:58 EDTTHORThoratec jumps 14% to $55.82 in early trading
Subscribe for More Information
July 17, 2015
08:07 EDTMDTMedtronic shares undervalued, says Wells Fargo
Subscribe for More Information
July 16, 2015
10:00 EDTMDTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Arc Logistics (ARCX) upgraded to Buy from Hold at Stifel... Dean Foods (DF) upgraded to Buy from Hold at Deutsche Bank... FreightCar America (RAIL) upgraded to Neutral from Sell at UBS... Frontier Communications (FTR) upgraded to Buy from Hold at Jefferies... Google (GOOG) upgraded to Outperform from Market Perform at BMO Capital... Intel (INTC) upgraded to Buy from Hold at Needham... Medtronic (MDT) upgraded to Buy from Neutral at BTIG... Netflix (NFLX) upgraded to Buy from Neutral at Rosenblatt... New Jersey Resources (NJR) upgraded to Buy from Hold at Argus... ONEOK Partners (OKS) upgraded to Outperform from Perform at Oppenheimer... Patterson-UTI (PTEN) upgraded to Overweight from Equal Weight at Morgan Stanley... SJM Holdings (SJMHY) upgraded to Overweight from Underweight at JPMorgan... Statoil (STO) upgraded to Buy from Neutral at Citi... SunOpta (STKL) upgraded to Outperform from Sector Perform at Scotia Howard Weil... Viacom (VIAB) upgraded to Neutral from Sell at Citi... Walgreens Boots Alliance (WBA) upgraded to Outperform from Neutral at Credit Suisse... Werner (WERN) upgraded on 'compelling' valuation at Wells Fargo... Wisconsin Energy (WEC) upgraded to Outperform from Neutral at Baird... voxeljet (VJET) upgraded to Overweight from Neutral at Piper Jaffray.
07:42 EDTMDTMedtronic upgraded to Buy from Neutral at BTIG
BTIG upgraded Medtronic to Buy with a $89 price target. The firm believes the recent pullback has provided a buying opportunity and views the company as well positioned for growth with revenue upside, strong cash deployment, and more Covidien synergies than some expect.
05:54 EDTMDTMedtronic recalls Shiley neonatal, pediatric tracheostomy tubes
Subscribe for More Information
July 15, 2015
10:59 EDTTHORHeartWare drops after analyst cuts target to $60
Shares of HeartWare are moving lower after Northland analyst Suraj Kalia cut his price target for the name to $60 from $70. The company manufactures implantable heart pumps for patients suffering from advanced heart failure. Recent sheep data for the company's MVAD Pump with new impeller design show a "flowrate profile that seems to be on a downtrend over time," Kalia told investors this morning in a research note. The incomplete data raise more questions, the analyst contends. The MVAD Pump is a continuous axial flow pump, one-third the size of HeartWare's current heart pump, HVAD, according to the company. Kalia believes the MVAD will be more "problematic in patient management" than the HVAD over the long term. The analyst has an Underperform rating on HeartWare, Northland's sell rating equivalent. Shares of medical device company are down $2.22 to $71.22 in morning trading. Its peer Thoratec (THOR) is up 16c to $46.69.
08:57 EDTTHORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
07:29 EDTMDTAmerican Orthopaedic Foot & Ankle Society to hold annual meeting
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use